SUBSCRIBE
SUBSCRIBE

Texas

LATEST FROM BIOSPACE
Lone Star Bio
Drug Prevents Type 2 Diabetes in Majority of High-Risk Individuals, Pennington Biomedical Research Center Study Finds
March 24, 2011
 · 
1 min read
Lone Star Bio
Transistor Performance Improves Due to Quantum Confinement Effects, University of Texas Study
March 22, 2011
 · 
1 min read
Lone Star Bio
Stem Cell Therapy Shrinks Enlarged Hearts, University of Miami Study
March 18, 2011
 · 
4 min read
Lone Star Bio
‘Pruned’ Microchips are Faster, Smaller, More Energy-Efficient, Rice University and Nanyang Technological University Study
March 17, 2011
 · 
1 min read
Lone Star Bio
In Men, Duration of Diabetes Linked to Raised Heart Risk, Texas A&M University Study Reveals
March 15, 2011
 · 
1 min read
Lone Star Bio
Nanotechnology Used in Gene Detection to Show Disposition to Certain Cancers, University of Texas Study
March 14, 2011
 · 
1 min read
Lone Star Bio
University of Texas Grads are Optimistic about Medical Device’s Market Potential
March 11, 2011
 · 
1 min read
Lone Star Bio
Researchers Say Cell Manipulation Could Lead to Better Drug Delivery Using Laser, University of Texas Reveals
March 11, 2011
 · 
1 min read
Lone Star Bio
World First Artificial Bronchus Graft in France, Avicenne Hospital Reveals
March 3, 2011
 · 
1 min read
Lone Star Bio
Over the Counter Pill Used Longer, University of Texas Study
February 28, 2011
 · 
1 min read
Load More
PRESS RELEASES
Press Releases
Decoy Therapeutics, Inc. Announces Up to $21 Million Private Placement Financing
June 28, 2026
 · 
5 min read
Press Releases
FibroBiologics Announces up to $9.0 Million Private Placement Priced At-the-Market Under Nasdaq Rules
June 26, 2026
 · 
6 min read
Press Releases
Medicenna Therapeutics Reports Fiscal Year 2026 Financial Results and Operational Highlights
June 26, 2026
 · 
11 min read
Press Releases
DecisionDx®-Melanoma’s i31-SLNB Outperforms MIA Nomogram in Identifying Patients Who May Safely Forgo Sentinel Lymph Node Biopsy
June 25, 2026
 · 
10 min read
Press Releases
Taysha Gene Therapies Announces Multiple Presentations Highlighting its TSHA-102 Clinical Program at the 2026 IRSF Rett Syndrome Scientific Meeting
June 25, 2026
 · 
7 min read
Press Releases
Natera and Eledon Announce Strategic Partnership for Prospera™ Monitoring in Planned Phase 3 Kidney Transplant Trial
June 25, 2026
 · 
8 min read
Press Releases
Plus Therapeutics Secures National Coverage Agreement with Elevance Health for CNSide® Cerebrospinal Fluid Assay for Metastatic CNS Cancer
June 25, 2026
 · 
3 min read
Press Releases
Taysha Gene Therapies Announces Pricing of Public Offering of Common Stock and Pre-Funded Warrants
June 25, 2026
 · 
5 min read
Press Releases
Ollin Biosciences Announces Oversubscribed $330 Million Series B Financing to Advance Global Phase 3 Development of OLN324 in DME and Wet AMD; Studies Commencing in Second Half of 2026
June 24, 2026
 · 
5 min read
Press Releases
Signatera™ Receives Regulatory Approval in Japan for Colorectal Cancer
June 24, 2026
 · 
5 min read
Load More